Page 11 - Domestic Markets

MSCI rejig could trigger $160 mn outflows from domestic markets: Edelweiss

While the global index provider hasn't added or deleted any Indian stocks, it has reduced weights of bluechip firms RIL, Infosys and HDFC

Investors didn't sell in May as Sensex posted biggest monthly gains of 2021

Snapping out of last month's underperformance, the domestic markets delivered returns better than its global peers

High demand from domestic travelers makes Goa fastest recovering market

India's hospitality industry witnessed a decline of 38.7% in revenue per available room (RevPAR) during Q1 2021 as compared to Q1 2020

We may consider acquisitions in South East Asia: Marico head Saugata Gupta

In an Q&A, Saugata Gupta, Marico's managing director and CEO, hails the Budget and lays out the company's road map for the future

Two routes to atmanirbharta: Why both China and India are looking inwards

While both have seen a drop in external trade in relation to GDP, the reasons are quite different - in China it is in part a problem of success, in India it points more to failure, writes T N Ninan

Market regulator's T+1 settlement proposal faces opposition from FPIs

Foreign investor body writes to the market regulator highlighting operational difficulties

India pips EM peers in latest market uptick as US stimulus brings hope

2020 underperformance narrows; Experts say going further outperformance could be a challenge

Sugar production to increase to 30.5 million tonnes in 2020-21: Ind-Ra

Ind-Ra said it expects sugar production to increase to 30.5 million tonnes in SS21, factoring in a cane diversion equivalent to 1.5 million tonnes of sugar

Govt issues scheme guidelines to boost drug manufacturing, medical devices

The objective is to make India self reliant in production of 53 critical Active Pharmaceutical Ingredients, and in production of medical devices, for which India is crucially dependent on imports

Rossari Biotech IPO subscribed 79.4 times, generates bids worth Rs 27K cr

Rossari is the first IPO to hit the domestic markets since a national lockdown was declared in early-March.

Risk of underperformance by domestic markets after April showing

Some believe that the best monthly performance in 11 years was on a weak footing, as it was sans any fundamental base

Investors should stick to stocks of firms focused on domestic market

Pharma firms can build brands and enjoy higher margins here

Growth in domestic market likely to provide booster dose for pharma stocks

The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row

Markets slump 4% as investors sentiment remain sombre due to coronavirus

Indian indices fall 4%; gloom prevails in other global markets also after Trump's dire warning

Domestic markets stabilise after worst single-day slump in about 5 years

The Sensex ended 62 points higher at 35,697, while the Nifty ended little changed at 10,458

Overseas listings dry up as Indian companies eye domestic market

The decadal average of funds raised through this route is currently at its lowest on record

Domestic drug market stares at supply crisis due to coronavirus outbreak

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Five reasons for the 900-point rally in the S&P BSE Sensex on Tuesday

All the Nifty sectoral indices are trading in the green. Nifty Bank, Nifty Financial Service, Nifty Metal, and Nifty Private Bank indexes gained over 2 per cent each

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

NSE seeks cut in tax on capital market transactions to boost investment

Vikram Limaye said several taxes, including the securities transaction tax and the goods and services tax, are hurting investor participation